$NWBO Headlines The Time Is Now For Northwest

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$NWBO Headlines

The Time Is Now For Northwest Biotherapeutics 3:16 p.m. Oct. 29, 2014 - Seeking Alpha
9 Biotechnology Stocks to Buy Now 6:15 a.m. Oct. 29, 2014 - InvestorPlace.com
Washington Post’s Pearlstein Didn't Intend to Disparage TheStreet’s Integrity 2:32 p.m. Oct. 28, 2014 - TheStreet.com
10 Biotechnology Stocks to Buy Now 6:00 a.m. Oct. 22, 2014 - InvestorPlace.com
10 Biotechnology Stocks to Buy Now 6:00 a.m. Oct. 15, 2014 - InvestorPlace.com
DXVAX-L Hospital Exemption Program Now Under Way In Germany 8:04 a.m. Oct. 14, 2014 - benzinga.com
Northwest Bio's Latest Financing Abuses Its Shareholders: Is The Charade Over? 2:26 p.m. Oct. 8, 2014 - Seeking Alpha
Update: Northwest Biotherapeutics Announces $11 Million Financing, Harms Shareholders Again 9:04 a.m. Oct. 8, 2014 - Seeking Alpha
Why Northwest Bio is Shunned by Savvy Healthcare Investors 7:43 a.m. Oct. 8, 2014 - TheStreet.com
8 Biotechnology Stocks to Buy Now 6:15 a.m. Oct. 8, 2014 - InvestorPlace.com
Northwest Biotherapeutics Misrepresents Clinical Trial Data 11:14 a.m. Oct. 1, 2014 - Seeking Alpha
9 Biotechnology Stocks to Buy Now 6:00 a.m. Oct. 1, 2014 - InvestorPlace.com
WP reporter writes a "hit piece" on (gasp!) Mr. Feuerstein 11:00 a.m. Sept. 30, 2014 - Seeking Alpha
TheStreet Seeks Retraction From Washington Post on Steven Pearlstein Column 10:14 a.m. Sept. 30, 2014 - TheStreet.com
The Case Of Northwest Biotherapeutics 1:35 p.m. Sept. 29, 2014 - Seeking Alpha
Northwest Biotherapeutics Valuation = $0 6:14 p.m. Sept. 26, 2014 - Seeking Alpha
7 Biotechnology Stocks to Buy Now 5:45 a.m. Sept. 24, 2014 - InvestorPlace.com
Update: Northwest Biotherapeutics Stock In Turmoil, But Not For Long 1:49 p.m. Sept. 23, 2014 - Seeking Alpha
Northwest Bio's Almost-Toxic Debt Raise Responsible for Stock Slide 8:59 a.m. Sept. 22, 2014 - TheStreet.com
Northwest Biotherapeutics: U.K. May Grant Early Patient Access For DCVax-L Prior To Formal Approval 4:02 a.m. Sept. 18, 2014 - Seeking Alpha


SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 2:41 p.m. Oct. 28, 2014 - PR Newswire - PRF
NORTHWEST BIOTHERAPEUTICS INC. ALERT -- Andrews & Springer LLC is Investigating Northwest Biotherapeutics Inc. for Potential Securities Fraud 8:01 a.m. Oct. 20, 2014 - GlobeNewswire
DCVAX®-L HOSPITAL EXEMPTION PROGRAM NOW UNDER WAY IN GERMANY 9:01 a.m. Oct. 14, 2014 - PR Newswire - PRF
NW BIO ANNOUNCES $11.5 MILLION FINANCING 9:00 a.m. Oct. 7, 2014 - PR Newswire - PRF
NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 8:00 a.m. Sept. 16, 2014 - PR Newswire - PRF
NW BIO CEO TO PRESENT AT SMi's 3rd ANNUAL CANCER VACCINES CONFERENCE IN LONDON 8:00 a.m. Sept. 15, 2014 - PR Newswire - PRF
NW BIO TO PRESENT UPDATES AT RODMAN RENSHAW 16TH ANNUAL GLOBAL INVESTMENT CONFERENCE 8:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 2:44 p.m. Aug. 19, 2014 - PR Newswire - PRF
NW BIO ANNOUNCES PRICING OF $17.5 MILLION OFFERING OF CONVERTIBLE NOTES 11:47 a.m. Aug. 14, 2014 - PR Newswire - PRF
NW BIO CORRECTS ONGOING FALSE CLAIMS BY FEUERSTEIN ABOUT PHASE III TRIAL OF DCVAX®-L, AND INTERIM ANALYSIS 9:26 a.m. Aug. 13, 2014 - PR Newswire - PRF
NW BIO PROVIDES UPDATE ABOUT PHASE III DCVAX®-L TRIAL FOR GBM AND "INFORMATION ARM" COMPASSIONATE USE PATIENTS 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
NW BIO OBTAINS APPROVALS FOR ENHANCEMENTS OF PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
Small companies lead the I-O class of Cancer Therapies 8:03 a.m. Aug. 8, 2014 - ACCESSWIRE
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 4:46 p.m. July 30, 2014 - BusinessWire - BZX
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Northwest Biotherapeutics, Inc. Stockholders 7:13 p.m. July 23, 2014 - BusinessWire - BZX
NW BIO ANNOUNCES COMPLETION OF DCVAX®-DIRECT PHASE I TRIAL RECRUITMENT 8:15 a.m. July 16, 2014 - PR Newswire - PRF
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 4:55 p.m. July 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 6:23 p.m. July 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Northwest Biotherapeutics, Inc. - NWBO 6:31 p.m. July 7, 2014 - PR Newswire - PRF
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Northwest Biotherapeutics, Inc. (NWBO) To Contact The Firm 1:17 p.m. July 4, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 10

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 3

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 5

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 8

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 7

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 5

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 6

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 7

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 5

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 5

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading

Top 5 Most Recently Viewed Articles

Orano Faces Increased Challenges in Niger Amid Control Issues

Updated Category News Views 273

Orano's Current Situation in Niger In recent months, Orano has raised concerns regarding its operations in Niger, particularly with respect to the governance of SOMAÏR, where it holds the majority share. This situation has been complex, as the decisions made during board meetings are no longer being enacted, leading Orano to confirm that the Nigerien authorities have...

Continue Reading
Central New Energy Showcases Innovations at Global Event

Updated Category News Views 133

Central New Energy Takes Center Stage Recently, a significant event took place at the Istanbul Expo Center when the World Energy Congress & Exhibition unfolded. This prestigious gathering, known for being one of the longest-running new energy industry events, attracted over 300 exhibitors who showcased innovative technologies and solutions in the energy sector....

Continue Reading
Challenges for Short Sellers in the Energy Sector Ahead

Updated Category News Views 124

Challenges Faced by Short Sellers in the Energy Sector As the new year begins, short sellers in the energy sector have encountered difficulties, reflected in approximately $21.9 billion in year-to-date mark-to-market losses. This statistic highlights a decrease of 1.59%. Ihor Dusaniwsky, the Managing Director of Predictive Analytics at S3 Partners, noted that both the...

Continue Reading
Innovative Projects by NIIMBL to Transform Biopharmaceuticals

Updated Category News Views 248

NIIMBL Launches New Projects to Revolutionize Biopharmaceutical Manufacturing The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has recently unveiled 11 transformative projects aimed at addressing various challenges in the biopharmaceutical sector. These initiatives are part of Project Call 8.1, with an impressive total funding of...

Continue Reading
Salarius and Decoy Merge: Pioneering Next-Gen Therapeutics

Updated Category News Views 168

Exciting Merger Completion Between Salarius Pharmaceuticals and Decoy Therapeutics This merger marks a strategic alliance designed to propel the development of advanced peptide conjugate therapeutics through Decoy’s innovative IMP3ACT platform. Together, this unified company begins its journey with a solid pro forma cash position of $14 million, following the merger and...

Continue Reading